Lansen Pharmaceutical Holdings Limited
HKEX:0503.HK
1.79 (HKD) • At close November 28, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 51.326 | 32.545 | 83.409 | 20.363 | 11.564 | 8.891 | 10.102 | 18.976 | 15.819 | 11.029 | 11.381 | 22.878 | 14.919 | 4.855 | 9.981 | 7.051 |
Short Term Investments
| 0 | 0 | 32.815 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 51.326 | 32.545 | 116.224 | 20.363 | 11.564 | 8.891 | 10.102 | 18.976 | 15.819 | 11.029 | 11.381 | 22.878 | 14.919 | 4.855 | 9.981 | 7.051 |
Net Receivables
| 35.087 | 38.883 | 31.825 | 36.292 | 84.816 | 105.987 | 92.292 | 80.276 | 97.108 | 72.423 | 63.477 | 42.159 | 29.283 | 20.592 | 19.076 | 9.771 |
Inventory
| 10.032 | 7.391 | 6.722 | 6.652 | 11.965 | 13.059 | 14.576 | 17.462 | 16.88 | 17.185 | 11.823 | 9.576 | 6.079 | 3.852 | 1.766 | 1.765 |
Other Current Assets
| 35.998 | 35.804 | 68.032 | 48.176 | 0.052 | 0.055 | 0.052 | 0.055 | 0.059 | 0.059 | 0.058 | 0.114 | 0.054 | 0.053 | 0.044 | 0.041 |
Total Current Assets
| 132.443 | 114.623 | 189.988 | 111.483 | 108.397 | 127.992 | 117.022 | 116.769 | 129.866 | 100.696 | 86.739 | 74.727 | 50.335 | 29.352 | 30.867 | 18.628 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 21.251 | 25.192 | 26.841 | 27.838 | 28.262 | 31.432 | 30.907 | 33.606 | 34.819 | 35.012 | 29.667 | 22.827 | 19.797 | 16.951 | 13.533 | 12.747 |
Goodwill
| 6.824 | 6.824 | 6.824 | 6.825 | 6.825 | 6.824 | 6.824 | 6.824 | 6.824 | 6.824 | 6.824 | 6.824 | 6.824 | 6.824 | 6.824 | 6.824 |
Intangible Assets
| 21.213 | 22.85 | 21.63 | 21.67 | 27.679 | 26.08 | 26.305 | 27.397 | 25.653 | 15.741 | 13.601 | 9.907 | 11.275 | 10.061 | 8.825 | 8.127 |
Goodwill and Intangible Assets
| 28.037 | 29.674 | 28.454 | 28.495 | 34.504 | 32.904 | 33.129 | 34.221 | 32.477 | 22.565 | 20.425 | 16.731 | 18.099 | 16.885 | 15.649 | 14.951 |
Long Term Investments
| 0.813 | 2.196 | -25.953 | 16.143 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0.859 | -2.196 | 0 | -16.143 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.555 | 2.823 | 33.448 | 16.143 | 30.75 | 35.417 | 41.704 | 33.69 | 35.113 | 34.109 | 32.031 | 30.16 | 24.38 | 0 | 0.328 | 0.616 |
Total Non-Current Assets
| 51.515 | 57.689 | 62.79 | 72.476 | 93.516 | 99.753 | 105.74 | 101.517 | 102.409 | 91.686 | 82.123 | 69.718 | 62.276 | 33.836 | 29.51 | 28.314 |
Total Assets
| 183.958 | 172.312 | 252.778 | 183.959 | 201.913 | 227.745 | 222.762 | 218.286 | 232.275 | 192.382 | 168.862 | 144.445 | 112.611 | 63.188 | 60.377 | 46.942 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 13.795 | 17.735 | 7.963 | 9.357 | 14.948 | 7.735 | 12.637 | 11.485 | 14.983 | 10.321 | 10.876 | 15.238 | 8.112 | 12.981 | 12.98 | 8.48 |
Short Term Debt
| 18.565 | 25.023 | 31.818 | 60.933 | 87.224 | 99.135 | 105.098 | 88.881 | 84.811 | 59.152 | 42.255 | 19.226 | 3.303 | 8.881 | 2.964 | 14.004 |
Tax Payables
| 0.777 | 0.539 | 0.87 | 1.406 | 0.512 | 1.096 | 1.402 | 1.473 | 1.776 | 1.566 | 0.968 | 1.303 | 1.147 | 0.258 | 0.199 | 0.217 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 27.605 | 10.717 | 11.706 | 10.177 | 8.845 | 16.856 | 12.775 | 13.835 | 16.883 | 11.881 | 10.147 | 1.303 | 1.147 | 0.569 | 0.999 | 1.495 |
Total Current Liabilities
| 59.965 | 53.475 | 51.487 | 80.467 | 111.017 | 123.726 | 130.51 | 114.201 | 116.677 | 81.354 | 63.278 | 35.767 | 12.562 | 22.431 | 16.943 | 23.979 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 0.031 | 0.204 | 0.782 | 0.481 | 0 | 0 | 0 | 1.09 | 0 | 0 | 0 | 9.157 | 7.39 | 10.407 | 20.57 | 1.924 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 2.012 | 2.032 | 3.227 | 1.636 | 2.445 | 2 | 1.876 | 1.548 | 0.993 | 0.378 | 0.181 | 0.181 | 0.394 | 0.394 | 0.122 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 2.043 | 2.236 | 4.009 | 2.117 | 2.445 | 2 | 1.876 | 2.638 | 0.993 | 0.378 | 0.181 | 9.338 | 7.784 | 10.801 | 20.692 | 1.924 |
Total Liabilities
| 62.008 | 55.711 | 55.496 | 82.584 | 113.462 | 125.726 | 132.386 | 116.839 | 117.67 | 81.732 | 63.459 | 45.105 | 20.346 | 33.232 | 37.635 | 25.903 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 4.204 | 3.773 | 3.972 | 3.972 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 29.491 | 29.491 | 29.491 |
Retained Earnings
| 93.739 | 86.07 | 162.425 | 74.547 | 58.405 | 67.56 | 64.355 | 61.102 | 59.501 | 46.745 | 36.357 | 23.72 | 13.942 | 3.565 | 2.953 | 0.371 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | -17.999 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 24.007 | 26.758 | 30.885 | 22.856 | 43.895 | 30.309 | 21.871 | 36.195 | 50.954 | 59.755 | 64.896 | 71.47 | 74.173 | -3.1 | -9.702 | -8.823 |
Total Shareholders Equity
| 121.95 | 116.601 | 197.282 | 101.375 | 88.451 | 102.019 | 90.376 | 101.447 | 114.605 | 110.65 | 105.403 | 99.34 | 92.265 | 29.956 | 22.742 | 21.039 |
Total Equity
| 121.95 | 116.601 | 197.282 | 101.375 | 88.451 | 102.019 | 90.376 | 101.447 | 114.605 | 110.65 | 105.403 | 99.34 | 92.265 | 29.956 | 22.742 | 21.039 |
Total Liabilities & Shareholders Equity
| 183.958 | 172.312 | 252.778 | 183.959 | 201.913 | 227.745 | 222.762 | 218.286 | 232.275 | 192.382 | 168.862 | 144.445 | 112.611 | 63.188 | 60.377 | 46.942 |